BDNF and depressive symptom measurement: Recently, Koike et al. [145] demonstrated that the BDNF/TrkB signaling pathways may be involved in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist on tail suspension and the novelty-suppressed feeding models of depression.